Nanostructures for site-specific delivery of oxaliplatin cancer therapy: Versatile nanoplatforms in synergistic cancer therapy

As a clinically approved treatment strategy, chemotherapy-mediated tumor suppression has been compromised, and in spite of introducing various kinds of anticancer drugs, cancer eradication with chemotherapy is still impossible. Chemotherapy drugs have been beneficial in improving the prognosis of ca...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Mohsen Bagheri, Mohammad Arad Zandieh, Mahshid Daryab, Seyedeh Setareh Samaei, Sarah Gholami, Parham Rahmanian, Sadaf Dezfulian, Mahsa Eary, Aryan Rezaee, Romina Rajabi, Ramin Khorrami, Shokooh Salimimoghadam, Peng Hu, Mohsen Rashidi, Alireza Khodaei Ardakan, Yavuz Nuri Ertas, Kiavash Hushmandi
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2024-01-01
Serija:	Translational Oncology
Teme:	Oxaliplatin Targeted delivery Chemoresistance Synergistic cancer therapy Gene and drug delivery
Online dostop:	http://www.sciencedirect.com/science/article/pii/S1936523323002243
Oznake:	Označite Brez oznak, prvi označite!